Company / Current Assets
Xeris Biopharma Holdings, Inc. Current Assets History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$240.3M
FY2025
5-year range
$142.6M / $240.3M
FY2021-FY2025
Trend
+43.3%
vs FY2024
Sector context
#180 of 213
Health Care
What the data says
Xeris Biopharma Holdings, Inc.'s current assets of $240M is lower than 85% of companies in the Health Care sector (FY2025). Current Assets has fluctuated over the past 6 years, ranging from $143M in FY2021 to $240M in FY2025.
Based on SEC 10-K filings.
$240M in FY2025 with a 5-year CAGR of +9.6%.
Improved from $156M to $240M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +8.8%
- 5-Year CAGR
- +9.6%
- 10-Year CAGR
- -
Sector benchmark
Bottom 15% in Health CareTop 85% of 213This company $240.3M Sector average $2.5B
▼
-90.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +9.6%, indicating consistent growth.
- In FY2025, current assets increased 43.3% year-over-year.
- Ranks #180 out of 213 companies in the Health Care sector.
- Lowest current assets in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.26 (distress zone, below 1.8 threshold)
- Negative profit margin: -27.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $240.3M | +43.3% |
| FY2024 | $167.7M | +7.3% |
| FY2023 | $156.3M | -16.4% |
| FY2022 | $186.8M | +31.0% |
| FY2021 | $142.6M | -6.3% |
| FY2020 | $152.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026